Deciphering the molecular descriptors that modulate the therapeutic applications of bisphosphonates as pathological deposition inhibitors and antiresorptive bone drugs for a further rational design of new drugs based on crystal growth inhibitors

Files in this item

This item appears in the following Collection(s)

Search Repository

Advanced Search


My Account